Kathryn E Weaver1, Julia H Rowland, Keith M Bellizzi, Noreen M Aziz. 1. Office of Cancer Survivorship, Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA. keweaver@wfubmc.edu
Abstract
BACKGROUND: Many US cancer survivors live years after diagnosis, which emphasizes the importance of healthcare access for survivors. It is not known whether having cancer has an impact on disparities in healthcare access that are present in the general population. The objective of this study was to examine the prevalence of forgoing care because of financial concerns in a representative sample of US adults to determine whether cancer history and race/ethnicity are associated with the likelihood of forgoing medical care. METHODS: Data from the US National Health Interview Survey (NHIS) from 2003 to 2006 were used to identify 6602 adult cancer survivors and 104,364 individuals who had no history of cancer. Self-reports of forgoing medical care services because of cost were analyzed according to cancer history and race/ethnicity using multivariate logistic regression. RESULTS: The prevalence of forgoing care because of cost among cancer survivors was 7.8% for medical care, 9.9% for prescription medications, 11.3% for dental care, and 2.7% for mental healthcare. Cancer survivors aged<65 years were more likely to delay or forego all types of medical care compared with adults who did not have a history of cancer. Hispanic and black cancer survivors were more likely to forego prescription medications and dental care than white survivors. Disparities among cancer survivors largely were reflective of those in the general adult population. CONCLUSIONS: More than 2 million US cancer survivors did not get 1 or more needed medical services because of financial concerns during the studied period. Future research needs to examine the impact of forgoing care on survivors' quality of life and survival.
BACKGROUND: Many US cancer survivors live years after diagnosis, which emphasizes the importance of healthcare access for survivors. It is not known whether having cancer has an impact on disparities in healthcare access that are present in the general population. The objective of this study was to examine the prevalence of forgoing care because of financial concerns in a representative sample of US adults to determine whether cancer history and race/ethnicity are associated with the likelihood of forgoing medical care. METHODS: Data from the US National Health Interview Survey (NHIS) from 2003 to 2006 were used to identify 6602 adult cancer survivors and 104,364 individuals who had no history of cancer. Self-reports of forgoing medical care services because of cost were analyzed according to cancer history and race/ethnicity using multivariate logistic regression. RESULTS: The prevalence of forgoing care because of cost among cancer survivors was 7.8% for medical care, 9.9% for prescription medications, 11.3% for dental care, and 2.7% for mental healthcare. Cancer survivors aged<65 years were more likely to delay or forego all types of medical care compared with adults who did not have a history of cancer. Hispanic and black cancer survivors were more likely to forego prescription medications and dental care than white survivors. Disparities among cancer survivors largely were reflective of those in the general adult population. CONCLUSIONS: More than 2 million US cancer survivors did not get 1 or more needed medical services because of financial concerns during the studied period. Future research needs to examine the impact of forgoing care on survivors' quality of life and survival.
Authors: Kenneth M Langa; A Mark Fendrick; Michael E Chernew; Mohammed U Kabeto; Kerry L Paisley; James A Hayman Journal: Value Health Date: 2004 Mar-Apr Impact factor: 5.725
Authors: Claire F Snyder; Craig C Earle; Robert J Herbert; Bridget A Neville; Amanda L Blackford; Kevin D Frick Journal: J Gen Intern Med Date: 2008-01-16 Impact factor: 5.128
Authors: K Robin Yabroff; William F Lawrence; Steven Clauser; William W Davis; Martin L Brown Journal: J Natl Cancer Inst Date: 2004-09-01 Impact factor: 13.506
Authors: Ahsan M Arozullah; Elizabeth A Calhoun; Michael Wolf; Denise K Finley; Karen A Fitzner; Elizabeth A Heckinger; Nicolle S Gorby; Glen T Schumock; Charles L Bennett Journal: J Support Oncol Date: 2004 May-Jun
Authors: Claire F Snyder; Craig C Earle; Robert J Herbert; Bridget A Neville; Amanda L Blackford; Kevin D Frick Journal: J Clin Oncol Date: 2008-03-01 Impact factor: 44.544
Authors: Claire F Snyder; Kevin D Frick; Kimberly S Peairs; Melinda E Kantsiper; Robert J Herbert; Amanda L Blackford; Antonio C Wolff; Craig C Earle Journal: J Gen Intern Med Date: 2009-01-21 Impact factor: 5.128
Authors: Donald H Taylor; Marion Danis; S Yousuf Zafar; Lynn J Howie; Gregory P Samsa; Steven P Wolf; Amy P Abernethy Journal: J Clin Oncol Date: 2014-08-25 Impact factor: 44.544
Authors: Ashley Wilder Smith; Keith M Bellizzi; Theresa H M Keegan; Brad Zebrack; Vivien W Chen; Anne Victoria Neale; Ann S Hamilton; Margarett Shnorhavorian; Charles F Lynch Journal: J Clin Oncol Date: 2013-05-06 Impact factor: 44.544
Authors: Nynikka R A Palmer; Ann M Geiger; Lingyi Lu; L Douglas Case; Kathryn E Weaver Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-10 Impact factor: 4.254
Authors: Janet S de Moor; Kisha Coa; Erin E Kent; Carmen Moten; Sarah Kobrin; Cheryl Altice; K Robin Yabroff Journal: J Cancer Surviv Date: 2018-10-03 Impact factor: 4.442